|
🐜
|
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
29 auth.
V. Rocha,
J. Cornish,
E. Sievers,
A. Filipovich,
F. Locatelli,
Christina Peters,
M. Remberger,
G. Michel,
W. Arcese,
S. Dallorso,
K. Tiedemann,
A. Busca,
K. Chan,
S. Kato,
J. Ortega,
...
M. Vowels,
A. Zander,
G. Souillet,
Anthony Oakill,
A. Woolfrey,
A. Pay,
A. Green,
F. Garnier,
I. Ionescu,
P. Wernet,
G. Sirchia,
P. Rubinstein,
S. Chevret,
E. Gluckman
|
9 |
2001 |
9
🐜
|
|
🐜
|
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
23 auth.
J. Finke,
W. Bethge,
C. Schmoor,
H. Ottinger,
M. Stelljes,
A. Zander,
L. Volin,
T. Ruutu,
D. Heim,
R. Schwerdtfeger,
...
K. Kolbe,
J. Mayer,
J. Maertens,
W. Linkesch,
E. Holler,
V. Koza,
M. Bornhäuser,
H. Einsele,
H. Kolb,
H. Bertz,
M. Egger,
O. Grishina,
G. Socié
|
9 |
2009 |
9
🐜
|
|
🐜
|
Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats.
7 auth.
C. Lange,
F. Tögel,
H. Ittrich,
F. Clayton,
C. Nolte-Ernsting,
A. Zander,
...
C. Westenfelder
|
8 |
2005 |
8
🐜
|
|
🐜
|
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
25 auth.
N. Kröger,
E. Holler,
G. Kobbe,
M. Bornhäuser,
R. Schwerdtfeger,
H. Baurmann,
A. Nagler,
W. Bethge,
M. Stelljes,
L. Uharek,
H. Wandt,
A. Burchert,
P. Corradini,
J. Schubert,
M. Kaufmann,
...
P. Dreger,
G. Wulf,
H. Einsele,
T. Zabelina,
H. Kvasnicka,
J. Thiele,
R. Brand,
A. Zander,
D. Niederwieser,
T. D. de Witte
|
8 |
2009 |
8
🐜
|
|
🐢
|
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.
N. Stute,
Katja Holtz,
M. Bubenheim,
C. Lange,
F. Blake,
A. Zander
|
8 |
2004 |
8
🐢
|
|
🐜
|
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
23 auth.
G. Socié,
C. Schmoor,
W. Bethge,
H. Ottinger,
M. Stelljes,
A. Zander,
L. Volin,
T. Ruutu,
D. Heim,
R. Schwerdtfeger,
...
K. Kolbe,
J. Mayer,
J. Maertens,
W. Linkesch,
E. Holler,
V. Koza,
M. Bornhäuser,
H. Einsele,
H. Kolb,
H. Bertz,
M. Egger,
O. Grishina,
J. Finke
|
8 |
2011 |
8
🐜
|
|
🐢
|
Accelerated and safe expansion of human mesenchymal stromal cells in animal serum‐free medium for transplantation and regenerative medicine
C. Lange,
F. Cakiroglu,
A. Spiess,
Heike Cappallo‐Obermann,
J. Dierlamm,
A. Zander
|
8 |
2007 |
8
🐢
|
|
🐢
|
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.
11 auth.
N. Kröger,
R. Schwerdtfeger,
M. Kiehl,
H. Sayer,
H. Renges,
T. Zabelina,
...
B. Fehse,
F. Tögel,
G. Wittkowsky,
R. Kuse,
A. Zander
|
8 |
2002 |
8
🐢
|
|
🐜
|
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.
23 auth.
C. Crawley,
M. Lalancette,
Richard Szydlo,
M. Gilleece,
K. Peggs,
S. Mackinnon,
G. Juliusson,
L. Ahlberg,
A. Nagler,
A. Shimoni,
...
A. Sureda,
J. Boiron,
H. Einsele,
R. Chopra,
A. Carella,
J. Cavenagh,
A. Gratwohl,
F. Garban,
A. Zander,
B. Björkstrand,
D. Niederwieser,
G. Gahrton,
J. Apperley
|
7 |
2005 |
7
🐜
|
|
🐜
|
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
18 auth.
M. Kiehl,
L. Kraut,
R. Schwerdtfeger,
B. Hertenstein,
M. Remberger,
N. Kroeger,
M. Stelljes,
M. Bornhaeuser,
H. Martin,
C. Scheid,
...
A. Ganser,
A. Zander,
J. Kienast,
G. Ehninger,
D. Hoelzer,
V. Diehl,
A. Fauser,
O. Ringdén
|
7 |
2004 |
7
🐜
|
|
🐢
|
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
12 auth.
N. Kröger,
H. Sayer,
R. Schwerdtfeger,
M. Kiehl,
A. Nagler,
H. Renges,
...
T. Zabelina,
B. Fehse,
F. Ayuk,
G. Wittkowsky,
N. Schmitz,
A. Zander
|
7 |
2002 |
7
🐢
|
|
🐜
|
Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population.
7 auth.
O. Kustikova,
A. Wahlers,
K. Kuhlcke,
Birgit Stahle,
A. Zander,
C. Baum,
...
B. Fehse
|
7 |
2003 |
7
🐜
|
